Jared Gollob

Company: Kymera Therapeutics

Job title: CMO

Seminars:

Industry Leaders Panel Discussion | 2021 in Review 9:30 am

What is the current state of play of the targeted protein degradation field? What are the most promising therapeutic candidates in the pipeline? What are the major challenges lying ahead in translating novel therapeutics from bench to bedside? Bivalency vs monovalency; what are the key advantages/disadvantages of both?Read more

day: Day One

Translating Targeted Protein Degradation Beyond Oncology 8:30 am

Establishing translating strategies for targeted protein degradation beyond oncologyRead more

day: Day One